Treatment Satisfaction of Galcanezumab in Japanese Patients With Episodic Migraine: A Phase 2 Randomized Controlled Study
mediaposted on 2021-03-25, 12:21 authored by Adis journals on behalf of, Yoshihisa Tatsuoka, Takao Takeshima, Akichika Ozeki, Taka Matsumura
Article full text
The above summary slide and graphical plain language summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.